|4Feb 2, 6:17 PM ET

Katz Richard D 4

4 · Allena Pharmaceuticals, Inc. · Filed Feb 2, 2021

Insider Transaction Report

Form 4
Period: 2021-02-01
Katz Richard D
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-02-01+400,000400,000 total
    Exercise: $1.67Exp: 2031-02-01Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]25% shall vest on 2/1/2022 and the remaining 75% shall vest in equal monthly installments over the following thirty-six (36) months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION